- Home
- CDT vs SBFM Comparison
CDT vs SBFM Comparison
Compare CDT & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDT
- SBFM
- Stock Information
- Founded
- CDT 2019
- SBFM 2006
- Country
- CDT United States
- SBFM United States
- Employees
- CDT N/A
- SBFM N/A
- Industry
- CDT Biotechnology: Pharmaceutical Preparations
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- CDT Health Care
- SBFM Health Care
- Exchange
- CDT Nasdaq
- SBFM Nasdaq
- Market Cap
- CDT 5.3M
- SBFM 4.6M
- IPO Year
- CDT N/A
- SBFM N/A
- Fundamental
- Price
- CDT $0.39
- SBFM $1.50
- Analyst Decision
- CDT
- SBFM Strong Buy
- Analyst Count
- CDT 0
- SBFM 1
- Target Price
- CDT N/A
- SBFM $15.00
- AVG Volume (30 Days)
- CDT 768.1K
- SBFM 784.6K
- Earning Date
- CDT 05-15-2025
- SBFM 05-15-2025
- Dividend Yield
- CDT N/A
- SBFM N/A
- EPS Growth
- CDT N/A
- SBFM N/A
- EPS
- CDT N/A
- SBFM N/A
- Revenue
- CDT N/A
- SBFM $34,874,283.00
- Revenue This Year
- CDT N/A
- SBFM $192.48
- Revenue Next Year
- CDT N/A
- SBFM N/A
- P/E Ratio
- CDT N/A
- SBFM N/A
- Revenue Growth
- CDT N/A
- SBFM 44.75
- 52 Week Low
- CDT $0.51
- SBFM $1.17
- 52 Week High
- CDT $350.00
- SBFM $23.20
- Technical
- Relative Strength Index (RSI)
- CDT 31.63
- SBFM 52.85
- Support Level
- CDT $0.38
- SBFM $1.24
- Resistance Level
- CDT $0.41
- SBFM $1.41
- Average True Range (ATR)
- CDT 0.04
- SBFM 0.10
- MACD
- CDT 0.01
- SBFM 0.04
- Stochastic Oscillator
- CDT 9.89
- SBFM 87.88
About CDT Conduit Pharmaceuticals Inc.
Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.